United States · Series B startup

Who invested in Icon Bioscience

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$32Mraised across 2 rounds since 2013, from 2 sources

$17MSeries A$15MSeries B
Latest round
Series B, $15MAug 2013
Biggest round
$17MSeries A · Jan 2013
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20132014
$17MSeries A$15MSeries B
First round
Series A, $17M
Jan 2013
Biggest round
$17M
Series A · Jan 2013
Between rounds
8 months
from the last two

The rounds

  1. Aug 2013
    Series B$15M

    No investor was named in the report.

    Reported by bizjournals.comSEC filing: $15M sold, first sale Aug 2013

  2. Jan 2013
    Series A$17M

    No investor was named in the report.

    From a historical funding record

Also claim to have backed them

This firm lists Icon Bioscience as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Signet Healthcare PartnersVC firmPer its own site

Quick answers about Icon Bioscience

How much has Icon Bioscience raised?

Icon Bioscience has raised $32M across 2 rounds since 2013.

When did Icon Bioscience last raise?

Icon Bioscience's most recent round was a Series B of $15M in Aug 2013.

What was Icon Bioscience's biggest round?

Icon Bioscience's largest round on record is $17M (Series A), in Jan 2013.

What stage is Icon Bioscience at?

Icon Bioscience's latest named round is a Series B, in Aug 2013.

Where is Icon Bioscience based?

Icon Bioscience is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.